| EMED Mining Public Limited Announces Management Update | |
| | |
|
NICOSIA, CYPRUS--(Marketwired - Dec 15, 2014) - EMED Mining Public Limited (TSX: EMD) (AIM: EMED)
EMED Mining Public Limited
("EMED" or the "Company")
Management Update
EMED, is today announcing that Mr. John Leach, the Company's Chief Financial Officer, is taking a leave of absence for health reasons. It is expected that Mr Leach will return to his role once his treatment is completed, which is expected to be by the end of January 2015.
In Mr Leach's absence EMED's finance function will be overseen by Mr Alberto Lavandeira Adan, the Company's Chief Operating Officer, supported by David Carrasco, CFO of EMED Tartessus, and George Hadjineophytou, Group Financial Controller - all of whom have been working closely with Mr Leach and all key parties as part of the ongoing discussions to finalise the required financing package.
Ronnie Beevor, Chairman of EMED commented: "On behalf of the Board, I would like to take this opportunity to wish John a speedy recovery and look forward to his return."
Enquiries
EMED Mining |
Ronnie Beevor/ Alberto Lavandeira Adan |
+34 959 59 28 50 |
Canaccord Genuity |
Neil Elliot/Mark Palmer |
+44 207 523 8000 |
Fox-Davies Capital |
Oliver Stansfield |
+44 203 463 5061 |
Walbrook PR |
Nick Rome |
+44 207 933 8783 |
For further information on the Company's activities, visit www.emed-mining.com.
This information is provided by RNS
The company news service from the London Stock Exchange
|
|
|
EMED Mining Public Ltd
|
|
DEVELOPMENT STAGE |
CODE : EMED.L |
ISIN : CY0000100319 |
|
| |
ProfileMarket IndicatorsVALUE : Projects & res.Press releasesAnnual reportRISK : Asset profileContact Cpy |
EMED is a gold and copper development stage company based in Cyprus. EMED develops gold, copper and zinc in Cyprus and in Spain, and holds various exploration projects in Cyprus. Its main assets in development are PROYECTO RIO TINTO in Spain and KLIROU in Cyprus and its main exploration properties are DETVA, STIAVNICA-HODRUSA and BIELY VRCH in Slovakia and KLIROU in Cyprus. EMED is listed in United Kingdom. Its market capitalisation is GBX 54.7 billions as of today (US$ 65.5 billions, € 57.4 billions). Its stock quote reached its lowest recent point on September 18, 2015 at GBX 0.12, and its highest recent level on January 17, 2022 at GBX 404.00. EMED has 135 475 650 shares outstanding. |